Capital Impact Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
Capital Impact Advisors's EXAS Position: Q3 2024 in Review
Capital Impact Advisors sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 12,572 shares — an estimated $531K sold.
Capital Impact Advisors first reported a position in EXAS in Q3 2020 and held it in 15 quarters. The position peaked at $9.23M in Q4 2020. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.
- Capital Impact Advisors reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
- Capital Impact Advisors sold 12,572 Exact Sciences shares in Q3 2024, an estimated $531K.
- Capital Impact Advisors first reported a position in Exact Sciences in Q3 2020 and held it in 15 quarters.
- Capital Impact Advisors's Exact Sciences position peaked at $9.23M in Q4 2020.
- 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.
Based on Capital Impact Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.